医学影像服务市场机会、成长动力、产业趋势分析与预测 2024 - 2032

2024 年全球医学影像服务市场价值为 6,489 亿美元，预计 2025 年至 2034 年期间的复合年增长率为 5.2%。慢性病发生率不断上升，加上全球人口快速老化，对医学影像服务的需求空前巨大。随着医疗保健提供者寻求更准确、更有效的方法来诊断和治疗各种疾病，先进影像技术的采用预计将加速。此外，随着医疗保健系统不断现代化并专注于早期疾病的检测和预防，医学影像服务市场将在全球医疗保健领域发挥越来越重要的作用。

市场涵盖各种影像方式，包括 X 光、MRI、超音波、电脑断层扫描 (CT)、核子造影和乳房 X 光摄影，每种方式都以独特的方式为整个市场扩张做出贡献。其中，X光成像占据主导地位，到2024年将占据相当大的市场份额。它具有价格低廉、可靠性高以及在从大型医院到小型诊所的医疗环境中广泛可用等特点，成为人们青睐的选择。全球可近性和易用性是推动X射线普及的关键因素，确保了其在医学诊断领域的持续相关性。

在最终用途方面，市场分为医院、诊断中心、诊所和门诊手术中心。 2024 年，医院占据了医学影像服务市场的最大份额，高达 46%。这些机构配备了广泛的影像技术，包括X光机、MRI扫描仪、CT扫描仪和核子影像设备，具有全面的诊断能力。医院在处理复杂和紧急病例方面发挥关键作用，其中先进的成像对于救生程序、创伤护理和手术通常至关重要。他们提供快速、精确的影像服务的能力使他们成为医疗保健生态系统中的关键参与者。

在美国，医学影像服务市场规模在2024年将达到2,169亿美元，巩固了美国在全球市场的领先地位。这种主导地位是由大量的医疗保健投资、有利的政府政策以及公众对医学影像在医疗保健中的重要性的认识提高所推动的。美国受益于强大的监管框架，有利于创新成像技术的批准和推出。随着老龄人口的成长和医疗改革的持续进行，美国市场有望进一步扩张，为未来几年的医学影像服务产业创造良好的前景。

目录

第 1 章：方法论与范围

第 2 章：执行摘要

第 3 章：产业洞察

• 产业生态系统分析
• 产业衝击力
  • 成长动力
    • 医学影像技术的渐进式创新与进步
    • 医疗支出增加
    • 老年人口基数快速成长，疾病负担加重
    • 人工智慧在放射学领域的出现与应用
    • 政府的有利倡议
  • 产业陷阱与挑战
    • 成像程序成本高昂
    • 报销政策的变化
• 成长潜力分析
• 监管格局
  • 我们
  • 欧洲
• 报销场景
• 技术格局
• 未来市场趋势
• 差距分析
• 波特的分析
• PESTEL 分析

第四章：竞争格局

• 介绍
• 公司市占率分析
• 公司矩阵分析
• 主要市场参与者的竞争分析
• 竞争定位矩阵
• 策略仪表板
• 战略展望矩阵

第 5 章：市场估计与预测：按模式，2021 年至 2034 年

• 主要趋势
• X射线影像
• 磁振造影
• 超音波
• 电脑断层扫描
• 核子造影
• 乳房X光检查

第 6 章：市场估计与预测：依最终用途，2021 年至 2034 年

• 主要趋势
• 医院
• 诊断中心
• 诊所
• 门诊手术中心

第 7 章：市场估计与预测：按地区，2021 年至 2034 年

• 主要趋势
• 北美洲
  • 我们
  • 加拿大
• 欧洲
  • 德国
  • 英国
  • 法国
  • 西班牙
  • 义大利
  • 瑞士
  • 荷兰
  • 波兰
  • 丹麦
  • 瑞典
• 亚太地区
  • 中国
  • 日本
  • 印度
  • 澳洲
  • 韩国
  • 纽西兰
  • 印尼
  • 泰国
  • 越南
• 拉丁美洲
  • 巴西
  • 墨西哥
  • 阿根廷
  • 哥伦比亚
  • 智利
  • 秘鲁
• 中东和非洲
  • 南非
  • 沙乌地阿拉伯
  • 阿联酋
  • 以色列
  • 伊朗

第八章：公司简介

• Akumin
• Alliance Medical (Life Healthcare Group)
• Capitol Health
• Carlisle Health
• Circle Health Group
• HCA International
• I-MED Radiology Network
• Integral Diagnostics
• Medica Group
• Nuffield Health
• Qscan Group Holdings
• Qure.ai
• RadNet
• Ramsay Health Care
• RAYUS Radiology
• Sonic Healthcare
• Spire Healthcare Group
• The Royal Marsden
• Vista Health

The Global Medical Imaging Services Market, valued at USD 648.9 billion in 2024, is anticipated to expand at a CAGR of 5.2% between 2025 and 2034. The driving force behind this robust growth can be attributed to several key factors. The increasing prevalence of chronic diseases, alongside a rapidly aging global population, is creating an unprecedented demand for medical imaging services. As healthcare providers seek more accurate and efficient ways to diagnose and treat a wide range of conditions, the adoption of advanced imaging technologies is expected to accelerate. Moreover, as healthcare systems continue to modernize and focus on early disease detection and prevention, the medical imaging services market is set to play an increasingly pivotal role in the global healthcare landscape.

The market spans various imaging modalities, including X-ray, MRI, ultrasound, computed tomography (CT), nuclear imaging, and mammography, each contributing to the overall market expansion in unique ways. Among these, X-ray imaging maintains a dominant position, representing a significant share of the market in 2024. X-ray technology remains a cornerstone in diagnosing a variety of conditions, from bone fractures to dental concerns and lung diseases. Its affordability, reliability, and widespread availability across healthcare settings, from large hospitals to smaller clinics, make it a favored choice. The global accessibility and ease of use are key elements that drive X-ray adoption, ensuring its continued relevance in medical diagnostics.

On the end-use front, the market is segmented into hospitals, diagnostic centers, clinics, and ambulatory surgical centers. Hospitals captured the largest portion of the medical imaging services market in 2024, holding an impressive 46% share. These institutions are equipped with an extensive array of imaging technologies, including X-ray machines, MRI scanners, CT scanners, and nuclear imaging devices, allowing for comprehensive diagnostic capabilities. Hospitals play a critical role in handling complex and emergency cases, where advanced imaging is often essential for life-saving procedures, trauma care, and surgeries. Their capacity to provide rapid and precise imaging services positions them as key players in the healthcare ecosystem.

In the United States, the medical imaging services market reached USD 216.9 billion in 2024, cementing the country's leading position in the global market. This dominance is driven by substantial healthcare investments, favorable governmental policies, and heightened public awareness about the importance of medical imaging in healthcare. The U.S. benefits from a strong regulatory framework that facilitates the approval and launch of innovative imaging technologies. With a growing elderly population and ongoing healthcare reforms, the U.S. market is poised for further expansion, creating a promising outlook for the medical imaging services sector in the years to come.

Table of Contents

Chapter 1 Methodology and Scope

• 1.1 Market scope and definitions
• 1.2 Research design
  • 1.2.1 Research approach
  • 1.2.2 Data collection methods
• 1.3 Base estimates and calculations
  • 1.3.1 Base year calculation
  • 1.3.2 Key trends for market estimation
• 1.4 Forecast model
• 1.5 Primary research and validation
  • 1.5.1 Primary sources
  • 1.5.2 Data mining sources

Chapter 2 Executive Summary

• 2.1 Industry 360⁰ synopsis

Chapter 3 Industry Insights

• 3.1 Industry ecosystem analysis
• 3.2 Industry impact forces
  • 3.2.1 Growth drivers
    • 3.2.1.1 Incremental innovations and advancements in medical imaging technology
    • 3.2.1.2 Rise in healthcare expenditure
    • 3.2.1.3 Increasing disease burden along with rapidly growing geriatric population base
    • 3.2.1.4 Emergence and adoption of artificial intelligence in radiology
    • 3.2.1.5 Favorable government initiatives
  • 3.2.2 Industry pitfalls and challenges
    • 3.2.2.1 High cost of imaging procedures
    • 3.2.2.2 Changes in reimbursement policies
• 3.3 Growth potential analysis
• 3.4 Regulatory landscape
  • 3.4.1 U.S.
  • 3.4.2 Europe
• 3.5 Reimbursement scenario
• 3.6 Technological Landscape
• 3.7 Future market trends
• 3.8 Gap analysis
• 3.9 Porter’s analysis
• 3.10 PESTEL analysis

Chapter 4 Competitive Landscape, 2024

• 4.1 Introduction
• 4.2 Company market share analysis
• 4.3 Company matrix analysis
• 4.4 Competitive analysis of major market players
• 4.5 Competitive positioning matrix
• 4.6 Strategy dashboard
• 4.7 Strategic outlook matrix

Chapter 5 Market Estimates and Forecast, By Modality, 2021 – 2034 ($ Mn)

• 5.1 Key trends
• 5.2 X-ray imaging
• 5.3 MRI
• 5.4 Ultrasound
• 5.5 Computed tomography
• 5.6 Nuclear imaging
• 5.7 Mammography

Chapter 6 Market Estimates and Forecast, By End Use, 2021 – 2034 ($ Mn)

• 6.1 Key trends
• 6.2 Hospitals
• 6.3 Diagnostic centers
• 6.4 Clinics
• 6.5 Ambulatory surgical centers

Chapter 7 Market Estimates and Forecast, By Region, 2021 – 2034 ($ Mn)

• 7.1 Key trends
• 7.2 North America
  • 7.2.1 U.S.
  • 7.2.2 Canada
• 7.3 Europe
  • 7.3.1 Germany
  • 7.3.2 UK
  • 7.3.3 France
  • 7.3.4 Spain
  • 7.3.5 Italy
  • 7.3.6 Switzerland
  • 7.3.7 Netherlands
  • 7.3.8 Poland
  • 7.3.9 Denmark
  • 7.3.10 Sweden
• 7.4 Asia Pacific
  • 7.4.1 China
  • 7.4.2 Japan
  • 7.4.3 India
  • 7.4.4 Australia
  • 7.4.5 South Korea
  • 7.4.6 New Zealand
  • 7.4.7 Indonesia
  • 7.4.8 Thailand
  • 7.4.9 Vietnam
• 7.5 Latin America
  • 7.5.1 Brazil
  • 7.5.2 Mexico
  • 7.5.3 Argentina
  • 7.5.4 Colombia
  • 7.5.5 Chile
  • 7.5.6 Peru
• 7.6 Middle East and Africa
  • 7.6.1 South Africa
  • 7.6.2 Saudi Arabia
  • 7.6.3 UAE
  • 7.6.4 Israel
  • 7.6.5 Iran

Chapter 8 Company Profiles

• 8.1 Akumin
• 8.2 Alliance Medical (Life Healthcare Group)
• 8.3 Capitol Health
• 8.4 Carlisle Health
• 8.5 Circle Health Group
• 8.6 HCA International
• 8.7 I-MED Radiology Network
• 8.8 Integral Diagnostics
• 8.9 Medica Group
• 8.10 Nuffield Health
• 8.11 Qscan Group Holdings
• 8.12 Qure.ai
• 8.13 RadNet
• 8.14 Ramsay Health Care
• 8.15 RAYUS Radiology
• 8.16 Sonic Healthcare
• 8.17 Spire Healthcare Group
• 8.18 The Royal Marsden
• 8.19 Vista Health